Medical Myth-busting: Unmasking the Role of Epithelial Cytokines and Emerging Biologics in CRSwNP - CME - Guideline Central

CME

Title
Medical Myth-busting: Unmasking the Role of Epithelial Cytokines and Emerging Biologics in CRSwNP
Link
Description
In this session, renowned experts will tackle the most common misconceptions about CRSwNP using a fun and fastpaced myth-busting format, just like your favorite investigative shows! Through interactive case discussions, immersive pathophysiology animations, real-life nasal endoscopy footage, and patient perspective videos, we’ll expose the truth behind the role of epithelial cytokines in inflammatory pathways, reveal the latest guidelines for management, and uncover the cutting-edge therapies reshaping treatment.
Target Audience
Allergists/immunologists, otolaryngologists, pulmonologists, and advanced practice providers
Learning Objectives
  • Identify the features of pathophysiology of CRSwNP as an epithelial-driven airway disease.
  • Analyze the role of epithelial cytokines in chronic rhinosinusitis with nasal polyps (CRSwNP)
  • Apply the latest guideline recommendations for the diagnosis and management of CRSwNP
  • Evaluate current and emerging therapies for the treatment of CRSwNP
Estimated Duration
45 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Pulmonology, Otolaryngology, Allergy and Immunology
Keywords
chronic rhinosinusitis with nasal polyps (CRSwNP)
Disclosures and Disclaimers
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be. By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product. Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
Accredited Providers
  • National Jewish Health
Commercial Support
  • AstraZeneca Pharmaceuticals
Activity Expiration Date
December 23, 2026
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit0.75 CreditsACCME- Accreditation Council for Continuing Medical Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.